![Business Of Biotech artwork](https://is2-ssl.mzstatic.com/image/thumb/Podcasts113/v4/98/4d/8f/984d8f97-ec8d-88ee-2644-2e8fbce0d1df/mza_8395847657442652094.jpg/100x100bb.jpg)
First AI Antibody In Humans with Aulos' Aron Knickerbocker
Business Of Biotech
English - July 15, 2024 10:00 - 1 hour - 47.3 MBManagement Business Science Life Sciences biopharmaceutical bioprocessing biopharma biologics medicine therapy startup venturecapital entrepreneur pharma Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed
We love to hear from our listeners. Send us a message.
Data drives decision-making at Aulos Bioscience. It's also driven the career trajectory of its CEO. On this week's episode of the Business of Biotech podcast, we get an introspective walk through Aron Kinickerbocker's strategically-orchestrated career path, from his early days in the labs at Bristol-Myers Squibb and Genentech to his leadership of Aulos Bioscience, a company that boasts the first AI-generated antibody in human clinical trials. We explore Aulos' innovative IL-2 antibody and the role AI played in its highly-targeted and toxicity-reducing design, and we do it in pragmatic fashion — Aron's not about the AI hype, he's about the AI data — and in its Phase 1/2 clinical trial, the data is looking pretty good.
Register for Bioprocess Online’s Bio Expo Live, being held July 30th through August 1st . This inaugural expo is a fantastic opportunity for biopharma companies and contract manufacturers to evaluate the latest and greatest from the comfort of your desktop or mobile device. Conveniently, we’ve broken down the lineup into Upstream Solutions July 30th, Downstream Solutions July 31st, and Quality, Analytical, and Data Solutions August 1st. It’s absolutely free to register for this series of short, digestible, and interactive sessions -- just hit the links above to register for Bio Expo Live today!